Bank of Nova Scotia’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.59M Sell
22,017
-22,460
-50% -$3.14M ﹤0.01% 695
2025
Q4
$7.29M Buy
44,477
+3,820
+9% +$598K 0.01% 548
2025
Q3
$5.44M Buy
40,657
+8,910
+28% +$1.08M 0.01% 536
2025
Q2
$3.95M Buy
31,747
+14,860
+88% +$1.89M 0.01% 551
2025
Q1
$2.15M Buy
+16,887
New +$2.6M ﹤0.01% 609
2022
Q2
Sell
-26,600
Closed -$5M 1247
2022
Q1
$5M Buy
+26,600
New +$5.05M 0.01% 589
2021
Q2
Sell
-2,387
Closed -$464K 1137
2021
Q1
$464K Sell
2,387
-786
-25% -$161K ﹤0.01% 957
2020
Q4
$608K Sell
3,173
-661
-17% -$120K ﹤0.01% 849
2020
Q3
$566K Sell
3,834
-1
-0% -$143 ﹤0.01% 849
2020
Q2
$474K Sell
3,835
-20,466
-84% -$2.41M ﹤0.01% 766
2020
Q1
$2.35M Sell
24,301
-32,136
-57% -$3.1M 0.01% 533
2019
Q4
$5.22M Buy
56,437
+2
+0% +$168 0.01% 515
2019
Q3
$4.33M Buy
+56,435
New +$4.94M 0.01% 511
2018
Q2
Sell
-264,300
Closed -$9.56M 933
2018
Q1
$9.56M Buy
264,300
+246,600
+1,393% +$8.67M 0.05% 290
2017
Q4
$642K Buy
17,700
+9,400
+113% +$340K ﹤0.01% 819
2017
Q3
$318K Buy
+8,300
New +$348K ﹤0.01% 870

Other funds holding RGEN

Bank of Nova Scotia's RGEN Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Repligen (RGEN) stake by 50% in Q1 2026, selling an estimated $3.14M and leaving 22,017 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Bank of Nova Scotia first reported a position in RGEN in Q3 2017 and has held it in 16 quarters since. The position peaked at $9.56M in Q1 2018. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Bank of Nova Scotia held 22,017 shares of Repligen worth $2.59M as of Q1 2026.
  • Bank of Nova Scotia sold 22,460 Repligen shares in Q1 2026, an estimated $3.14M.
  • Repligen made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #695 holding.
  • Bank of Nova Scotia first reported a position in Repligen in Q3 2017 and has held it in 16 quarters since.
  • Bank of Nova Scotia's Repligen position peaked at $9.56M in Q1 2018.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.